Early and sustained improvements in patient-reported outcomes with tralokinumab in combination with topical corticosteroids as needed in moderate-to-severe atopic dermatitis

被引：0
|
作者：
Elewski, B. E. [1 ]
Staender, S. [2 ,3 ]
Zirwas, M. [4 ]
Silvestre, J. F. [5 ]
Kalia, S. [6 ,7 ,8 ]
Gutermuth, J. [9 ,10 ]
Mark, T. [11 ]
Tindberg, A. M. [11 ]
Silverberg, J. I. [12 ]
机构：
[1] Univ Alabama Birmingham, Birmingham, AL USA
[2] Univ Hosp Munster, Dept Dermatol, Munster, Germany
[3] Univ Hosp Munster, Interdisciplinary Competence Ctr Chron Pruritus K, Munster, Germany
[4] Prob Med Res, Columbus, OH USA
[5] Hosp Gen Univ Alicante, Dermatol Dept, Alicante, Spain
[6] Univ British Columbia, Dept Dermatol & Skin Sci, Vancouver, BC, Canada
[7] Vancouver Coastal Hlth, Vancouver, BC, Canada
[8] BC Childrens Hosp Res Inst, Vancouver, BC, Canada
[9] Univ Ziekenhuis Brussel, Dept Dermatol, Brussels, Belgium
[10] Vrije Univ Brussel, Brussels, Belgium
[11] LEO Pharma AS, Ballerup, Denmark
[12] George Washington Univ, Sch Med & Hlth Sci, Depat Dermatol, Washington, DC 20052 USA
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2021年 / 184卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
385
引用
收藏
页码：E83 / E84
页数：2
相关论文
共 50 条
  • [41] Dupilumab offers early and sustained improvement in sleep in adolescents with moderate-to-severe atopic dermatitis
    Beck, L. A.
    Simpson, E. L.
    Hong, H. C. H.
    Bansal, A.
    Chen, Z.
    Mina-Osorio, P.
    Prescilla, R.
    Gadkari, A.
    BRITISH JOURNAL OF DERMATOLOGY, 2020, 183 (04) : E95 - E95
  • [42] Dupilumab Offers Early and Sustained Improvement in Sleep in Adolescents With Moderate-to-Severe Atopic Dermatitis
    Simpson, Eric
    Eckert, Laurent
    Hong, Chih-Ho
    Bansal, Ashish
    Chen, Zhen
    Prescilla, Randy
    Gadkari, Abhijit
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2020, 18 : 23 - 24
  • [43] Predicting success with reduced dosing frequency of tralokinumab in patients with moderate-to-severe atopic dermatitis
    Weidinger, Stephan
    Bewley, Anthony
    Hong, H. Chih-ho
    Silvestre, Juan Francisco
    Peris, Ketty
    Wollenberg, Andreas
    Ivens, Ulla
    Soehoel, Anders
    Steffensen, Louise Abildgaard
    Tindberg, Ann-Marie
    Simpson, Eric L.
    BRITISH JOURNAL OF DERMATOLOGY, 2025, 192 (03) : 410 - 419
  • [44] A critical evaluation of suitability of tralokinumab for treatment of moderate-to-severe atopic dermatitis in adolescents and adults
    Pezzolo, Elena
    Sechi, Andrea
    Tartaglia, Jacopo
    Naldi, Luigi
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2024, 20 (03) : 255 - 266
  • [45] Patient-reported outcomes in atopic dermatitis and psoriasis
    Secrest, A. M.
    Gale, C. M.
    Gardiner, A.
    Hess, R.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2019, 139 (05) : S103 - S103
  • [46] USE OF TOPICAL CORTICOSTEROIDS WITH TRALOKINUMAB IN ADULT PATIENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS: RESULTS FROM THE 32-WEEK, PHASE 3 ECZTRA 3 TRIAL
    Silverberg, Jonathan I.
    Pink, Andrew E.
    Kurbasic, Azra
    Olsen, Christina Kurre
    Weidinger, Stephan
    ACTA DERMATO-VENEREOLOGICA, 2021, 101 : 55 - 55
  • [47] Long-term improvements observed in tralokinumab-treated patients with moderate-to-severe atopic dermatitis: an ECZTEND interim analysis
    Blauvelt, A.
    Lacour, J. -P.
    Toth, D.
    Laquer, V.
    Beissert, S.
    Wollenberg, A.
    Herranz, P.
    Pink, A.
    Peris, K.
    Fangel, S.
    Saeki, H.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (03) : E112 - E113
  • [48] A Patient-Reported Historical Disease Course and Flare Frequency in Adults With Moderate-to-Severe Atopic Dermatitis-A Pilot Study
    Grinich, Erin E. E.
    Dizon, Matthew P. P.
    Topham, Christina
    Chung, Janice
    Simpson, Eric L. L.
    DERMATITIS, 2022, 33 (6S) : S146 - S147
  • [49] Achieving a deep response on patient-reported outcomes with upadacitinib in patients with moderate-to-severe atopic dermatitis: results from three phase III trials
    Chovatiya, R.
    Schuttelaar, M. -L.
    Calimlim, B.
    Liu, Y.
    Takemoto, S.
    Staender, S.
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (04) : E161 - E161
  • [50] Dupilumab with Topical Corticosteroids Provides Rapid and Sustained Improvement in Adults with Moderate-to-Severe Atopic Dermatitis Across Anatomic Regions Over 52 Weeks
    Andrew Blauvelt
    Marjolein de Bruin-Weller
    Eric L. Simpson
    Zhen Chen
    Annie Zhang
    Brad Shumel
    Dermatology and Therapy, 2022, 12 : 223 - 231
12345